Lansoprazol Omnicals

Lansoprazole, the active ingredient in Lansoprazol Omnicals, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production in adults with acid‑related gastrointestinal conditions.

GNH USA supplies Lansoprazol Omnicals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that lowers gastric acidity in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: accelerates ulcer healing and helps prevent recurrence. - NSAID‑induced gastric ulcer: protects the gastric mucosa and facilitates ulcer resolution. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with appropriate antibiotics.

Lansoprazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate pain often resolving without treatment. - Diarrhea: loose stools that may be self‑limiting. - Abdominal pain: discomfort or cramps in the stomach area. - Nausea: feeling of unease or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema): require immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Low magnesium (hypomagnesemia): can lead to muscle cramps, seizures, or cardiac arrhythmias. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare but life‑threatening skin reactions.

Before prescribing Lansoprazol Omnicals, clinicians should consider several safety aspects. - Assess renal function: dose may need adjustment in severe renal impairment. - Monitor magnesium levels: prolonged use can cause hypomagnesemia. - Avoid abrupt discontinuation: may result in rebound acid hypersecretion. - Use with caution in hepatic impairment: monitor liver enzymes periodically. - Pregnancy and lactation: consult a prescriber; safety data are limited. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Lansoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, potentially lowering antiviral efficacy. - High‑dose methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk; monitor coagulation parameters. - Digoxin: possible rise in serum levels; check cardiac function. - Diazepam: may increase plasma concentration, enhancing sedative effects.